- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
As the COVID-19 pandemic continues to sweep across the US, around 12% of intensive care hospitalized COVID-19 patients need to be placed on a ventilator. Not only does the procedure to do this require thousands of patients to be sedated, but they must also remain sedated if they have to stay on a ventilator longer-term. This […]
Security and privacy concerns of telemedicine still need to be addressed, says GlobalData
The adoption of telemedicine has been accelerated significantly in the wake of COVID-19 outbreak. However, despite the increasing usage of the telehealth solutions, this innovation raises the same old questions related to security and privacy concerns, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, Senior Director of Market Research at GlobalData, comments: “If […]
COVID-19 vaccine immunity will require a concerted effort, says GlobalData
In order to achieve ‘herd immunity’ to COVID-19, there are estimates that anywhere from 50–90% of the population will need to achieve immunity. This will require a large amount of coordination and rapid deployment of vaccines to the general population, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: […]
Resurgence in the US and Europe will be bigger, harder to detect and harder to control, says GlobalData
Countries are beginning to reopen due to economic and social pressures, while keeping an eye on the threat of resurgences. Based on trends observed in Asia, GlobalData epidemiologists expect that there will be resurgences in the US and Europe. However, resurgence in the US and Europe will be bigger, harder to detect, and harder to […]
Comorbidity a major concern in people with angina pectoris, says GlobalData
Comorbidity is a major concern in people with angina pectoris as, in 2019, there were nearly 20 million diagnosed prevalent cases of angina pectoris in the 7MM, according to GlobalData, a leading data and analytics company. More than 60% had one or more comorbidities, the most common of which was hypertension. Topias Lemetyinen, Managing Epidemiologist […]
Myelodysplastic syndrome diagnosed incident cases set to reach 112,000 in 2028, says GlobalData
The burden of diagnosed myelodysplastic syndrome (MDS) is expected to increase at an annual growth rate (AGR) of 2.40% from around 90,000 cases in 2018 to 112,000 cases in 2028 in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Myelodysplastic Syndrome: Epidemiology Forecast to 2028’, reveals […]
COVID-19 deaths are being underreported, says GlobalData
COVID-19 deaths are most likely being underreported in the US, according to GlobalData, a leading data and analytics company. Excess deaths measure the difference between observed number of deaths and expected number of deaths. GlobalData calculates that there have been approximately 47,000 to 52,000 excess deaths since February 2, 2020. The causes of these excess […]
Technologies will help but not solve the emerging COVID-19 mental health crisis, says GlobalData
The COVID-19 pandemic presents significant growth opportunities for mental health and wellbeing technologies, however, telemedicine cannot replace in-person visits and these innovations will not resolve the upcoming crisis as it is novel and unprecedented, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, MSc, Senior Director of Market Research, commented: “The pandemic is predicted […]
GS-441524 could finally get trialed for feline infectious peritonitis in cats
Clinical trial results for Gilead Science’s remdesivir have shown modest improvement in the recovery of moderately ill COVID-19 patients and remdesivir’s success in humans could mean that GS-441524 will finally get trialed for feline infectious peritonitis (FIP) in cats, says GlobalData. Gilead Sciences published preliminary results from another Phase III study of its antiviral drug […]
Further research on MIS-C can provide insights on how COVID-19 affects immune system, says GlobalData
Some children have developed a severe inflammatory response due to COVID-19 infection that appears similar to Kawasaki disease. Doctors are referring to this response as pediatric multisystem inflammatory syndrome, or multisystem inflammatory syndrome in children (MIS-C). Although severe COVID-19 illness is less frequent in children, with about 3% of confirmed cases in the US in […]
ALS Global Day reiterates the need for an elusive cure despite promising late-stage pipeline
The International Alliance of Amyotrophic Lateral Sclerosis (ALS)/ Motor Neuron Disease (MND) Associations, recognizes June 21 as the ALS Global Day. The goal of this yearly campaign is to promote global awareness and raise funds for ALS research activities. Sarah Elsayed, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on […]
Bio/Pharma companies with COVID-19 drug in pipeline had smaller Q1 market cap decrease, says GlobalData
Having a COVID-19 drug in a bio/pharma company’s pipeline resulted in a smaller decrease in market capitalization (market cap) during the first quarter (Q1) of 2020 compared to companies that did not have a COVID-19 drug in their plan. Bio/pharma companies with a COVID-19 drug in their pipeline declined in aggregate market cap by 5.8%, […]
Acute myeloid leukemia market to reach $5.1bn by 2029 driven by novel agents and label expansions
The acute myeloid leukemia (AML) market is expected to grow from $1.4bn in 2019 to $5.1bn in 2029 across the eight major markets (8MM*) at a high compound annual growth rate (CAGR) of 13.6%, according to GlobalData, a leading data and analytics company. This growth will be driven by label expansions of the already successful […]
Taltz’s Nr-axSpA approval not enough to beat Cosentyx in axSpA
Despite receiving Food and Drug Administration (FDA) approval for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA) before Novartis’s Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) will not overthrow Cosentyx as the premiere anti-interleukin (IL) 17 biologic in the axSpA space. Taltz is forecast to achieve 2028 sales of $239m across the seven major markets (7MM*), whereas […]
Serum Institute of India will play pivotal role in development of COVID-19 vaccines, says GlobalData
Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently working on three candidates for COVID-19, including the testing of its recombinant-BCG vaccine in Phase 3 clinical trials at several locations across India. With these, SII continues to play a pivotal role in the development and commercialization […]
Results from study show oral selexipag for PAH effective and safe in children, says GlobalData
Oral selexipag could improve treatment for the pediatric population based on its convenient administration, better safety and better tolerability profile compared to currently available options according to GlobalData, a leading data and analytics company. Selexipag is the only prostacyclin receptor agonist approved to target the prostacyclin pathway in adults with PAH, and is indicated for […]
Fourteen of top 20 pharmaceutical companies by MCap see double-digit MCap growth in 2019, says GlobalData
The pharma sector saw promising year-on-year (YoY) growth in 2019, compared to the previous year, with 16 of the top 20 companies by market capitalization (MCap) recording positive MCap growth and 14 companies seeing a double-digit growth rate. Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100% YoY growth […]
Latin America has not yet reached peak COVID-19 cases, says GlobalData
Latin American countries are showing dangerous trends of increasing COVID-19 cases. Brazil, Peru, Chile, and Mexico are now ranked second, tenth, thirteenth, and fourteenth, respectively, in the number of COVID-19 cases. GlobalData forecasts that these markets have not yet reached peak case numbers. It is likely that the outbreak will continue to worsen in Latin […]
Machine learning can aid in COVID-19 epidemiology, says GlobalData
As the COVID-19 pandemic continues to evolve across the globe, a large amount of data on its epidemiology has been generated. Finding relationships and predictive factors in this data can be aided by the application of machine learning and neural networks to find complex patterns in the data more efficiently and help predict the future […]
COVID-19 pandemic swallows 18% clean energy jobs, stalling years of industry growth, says GlobalData
The clean energy sector had been one of the biggest and fastest-growing sectors in the US since 2015, having employed over 3 million people. However, during March, April, and May, over half a million clean energy workers lost their jobs in the US and filed for unemployment benefits. The total clean energy job loss stands […]